Tina Susan Nova - Jun 15, 2023 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
Executive Chairperson, Director
Signature
/s/ Kamal Adawi, Attorney-in-Fact
Stock symbol
XGN
Transactions as of
Jun 15, 2023
Transactions value $
$0
Form type
4
Date filed
6/20/2023, 04:30 PM
Previous filing
Feb 15, 2023
Next filing
Feb 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XGN Stock Option(right to buy) Award $0 +13.5K $0.00 13.5K Jun 15, 2023 Common Stock 13.5K $3.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The entire number of shares subject to this option becomes fully vested and exercisable on the earlier of June 9, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date.